Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation., Nishihara Shigetoshi;Yamaoka Toshimitsu;Ishikawa Fumihiro;Ohmori Tohru;Ando Koichi;Kusumoto Sojiro;Kishino Yasunari;Manabe Ryo;Hasebe Yuki;Sagara Hironori;Yoshida Hitoshi;Tsurutani Junji, Cells, 11(14), 2022年07月, 原著, 査読あり